ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1059

The Negative Impact of Physicians’ Neuroticism and Conscientiousness on Shared Decision Making in Patients with Systemic Lupus Erythematosus: The TRUMP2-SLE Project

Shigemi Morishita1, Kenei Sada2, Masataka Kudo3, Naofumi Dobashi4, Ryusuke Yoshimi5, Natsuki Sakurai6, Chiharu Hidekawa6, Yasuhiro Shimojima7, Dai Kishida7, Takanori Ichikawa7, Yoshi Miyawaki8, Keigo Hayashi9, Kenta Shidahara10, Yuichi Ishikawa11, Nao Oguro12, Nobuyuki Yajima13 and Noriaki Kurita14, 1Department of Surgery, Oida Hospital, Sukumo, Japan, 2Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan, 3Department of General Internal Medicine, Iizuka Hospital, Fukuoka, Japan, 4Department of Internal Medicine, Kochi Prefectural Hata-Kenmin Hospital, Sukumo, Japan, 5Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Yokohama, Kanagawa, Japan, 6Department of Stem Cell and Immune Regulation,Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan, 7Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Nagano, Japan, 8Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 9Brigham and Women’s Hospital, Brookline, MA, 10"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan, 11The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan, 12Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan, 13Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Tokyo, Japan, 14Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima, Japan

Meeting: ACR Convergence 2024

Keywords: Patient reported outcomes, quality of care, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Measures & Measurement of Healthcare Quality Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The treatment of systemic lupus erythematosus (SLE) remains challenging due to its complexity, despite the introduction of various promising treatments. Recent EULAR recommendations emphasize the necessity of shared decision-making (SDM) for the multidisciplinary and individualized management of SLE.1 Studies have indicated that certain physicians’ personality traits can affect patient outcomes.2 This study aimed to investigate the relationship between the Big Five personality traits of attending rheumatologists and SDM.

Methods: This cross-sectional study utilized baseline data from the Trust Measurements for Physicians and Patients with SLE (TRUMP2-SLE) study. Data were gathered from electronic medical records and self-administered questionnaires between June 2020 and August 2021. The primary exposures in this study were the Big Five personality traits (extraversion, agreeableness, conscientiousness, neuroticism, and openness) of the attending rheumatologists, measured by the Japanese version of the 10-Item Personality Inventory (TIPI-J) scale (1-7 points for each item). The outcome measure was shared decision-making (SDM), assessed by the patient version of the 9-item SDM Questionnaire (SDM-Q-9) scale (0-100 points). Multivariate linear regression was applied to evaluate the relationship between TIPI-J scores and SDM-Q-9 scores, using cluster-robust variance estimation with each rheumatologist as a cluster unit.

Results: In total, 493 patients with SLE were included in this study. The participants’ median (interquartile range [IQR]) age was 45.3 (36.0-54.9) years, and 437 (88.6%) were women. Their median (IQR) disease duration of SLE was 10.2 (3.9-17.3) years. The median (IQR) score of the SDM-Q-9 for the patients was 75.6 (66.2-88.9). The median (IQR) age of the 43 attending rheumatologists was 39.0 (34.0-43.0) years, and 10 (23.3%) were women. The median (IQR) number of patients per attending rheumatologist who participated in this study was 4 (1.5-14.5). The median (IQR) scores of each component on the TIPI-J scale were as follows: extraversion, 4.0 (3.0-5.0); agreeableness, 5.0 (4.5-5.5); conscientiousness, 3.0 (3.0-4.0); neuroticism, 3.5 (3.0-4.5); and openness, 4.0 (3.0-5.0). Multivariable linear regression analysis showed that higher agreeableness was related to a higher SDM-Q-9 score, while higher conscientiousness and neuroticism were negatively related to SDM-Q-9 scores, even after adjusting for confounding variables (Table 1).

Conclusion: Neuroticism and conscientiousness are reportedly personality traits related to perfectionism.3 The results of our study suggest that physicians’ perfectionism in the treatment of SLE negatively affects SDM.

References  

1. Fanouriakis A, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83:15-29.

2. Sada K-E, et al. Grit personality of physicians and achievement of treatment goals in patients with systemic lupus erythematosus. Rheumatology. 2023;62:2154-2159.

3. Stricker J, et al. Multidimensional Perfectionism and the Big Five Personality Traits: A Meta-Analysis. Eur J Pers. 2019;33:176-196.

Supporting image 1


Disclosures: S. Morishita: None; K. Sada: GlaxoSmithKlein(GSK), 6; M. Kudo: None; N. Dobashi: None; R. Yoshimi: None; N. Sakurai: None; C. Hidekawa: None; Y. Shimojima: None; D. Kishida: None; T. Ichikawa: None; Y. Miyawaki: None; K. Hayashi: None; K. Shidahara: None; Y. Ishikawa: None; N. Oguro: None; N. Yajima: None; N. Kurita: GlaxoSmithKlein(GSK), 2.

To cite this abstract in AMA style:

Morishita S, Sada K, Kudo M, Dobashi N, Yoshimi R, Sakurai N, Hidekawa C, Shimojima Y, Kishida D, Ichikawa T, Miyawaki Y, Hayashi K, Shidahara K, Ishikawa Y, Oguro N, Yajima N, Kurita N. The Negative Impact of Physicians’ Neuroticism and Conscientiousness on Shared Decision Making in Patients with Systemic Lupus Erythematosus: The TRUMP2-SLE Project [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/the-negative-impact-of-physicians-neuroticism-and-conscientiousness-on-shared-decision-making-in-patients-with-systemic-lupus-erythematosus-the-trump2-sle-project/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-negative-impact-of-physicians-neuroticism-and-conscientiousness-on-shared-decision-making-in-patients-with-systemic-lupus-erythematosus-the-trump2-sle-project/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology